[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369016-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369016-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-the-expression-and-prognostic-roles-of-lad1-in-lung-adenocarcinoma","Exploring the expression and prognostic roles of LAD1 in lung adenocarcinoma","","Lung adenocarcinoma (LUAD) is a common non-small cell lung cancer subtype with poor outcomes. To find novel biomarkers and clarify mechanisms, the study integrates single-cell and bulk RNA sequencing analyses, focusing on LAD1, a basement membrane filament protein implicated in tumor biology. LAD1 shows cancer-cell–specific expression and strong correlations with LUAD progression genes. Clinical tissue validation and functional knockdown experiments further support LAD1 as highly expressed in LUAD and linked to migration and invasion, with prognostic and predictive modeling results.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-the-expression-and-prognostic-roles-of-lad1-in-lung-adenocarcinoma/369016/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-the-expression-and-prognostic-roles-of-lad1-in-lung-adenocarcinoma/369016.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data types and analysis strategies were used to study LAD1 in LUAD?","Question",{"text":63,"@type":64},"The study uses single-cell RNA sequencing and bulk RNA sequencing for comprehensive analyses, including DEG, biological process, and signaling pathway investigations, along with clinical tissue correlation analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Where is LAD1 expressed within LUAD tumors according to the single-cell results?",{"text":68,"@type":64},"LAD1 is specifically expressed in cancer cells within the LUAD tumor cell subgroup, rather than broadly across all examined cell types.",{"name":70,"@type":61,"acceptedAnswer":71},"How does LAD1 knockdown affect LUAD cell behavior?",{"text":72,"@type":64},"siRNA-mediated LAD1 knockdown in A549 cells inhibits LUAD cell migration and invasion, supported by scratch healing and Transwell assays.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369016,1790218316,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nExploring the expression and prognostic roles of LAD1 in lung adenocarcinoma  \nSufen Wang1,4􀀍, Banghong Qiang2,4, Xiaoyan Xu3, Yan Fang1, Yinhua Liu1, Wei Zhang1 & Xi Huang1  \nLung adenocarcinoma (LUAD) is a common subtype of non-small cell lung cancer (NSCLC) with a poor prognosis. To identify novel biomarkers and understand the underlying mechanisms in LUAD, we conducted a comprehensive analysis using single-cell and bulk RNA sequencing data. Our study focused on LAD1, a basement membrane filament protein that has been implicated in tumorigenesis in various cancers. We analyzed scRNA-seq data from 10 LUAD patients and identified nine cell subgroups, with LAD1 specifically expressed in cancer cells. Further analysis revealed significant correlations between LAD1 and genes associated with LUAD progression, including SFTPB, S100A6, CEACAM6, KRT19, S100A10, ANXA2, S100A11, and CAPN2. We investigated the effects of altered LAD1 expression on differentially expressed genes (DEGs), biological processes, and signaling pathways. Furthermore, we collected cancer tissue and corresponding adjacent tissue samples from 36 LUAD patients, used immunohistochemical staining to detect LAD1 expression, and analyzed its correlation with clinicopathological characteristics. We knocked down the expression of LAD1 in A549 cells using siRNA, and detected changes in LUAD cell migration and invasion ability through scratch healing assay and Transwell assay. Our results indicated diverse effects of LAD1 at both the single-cell and whole tumor levels, with a convergence on processes associated with tumor progression. In lung adenocarcinoma tissues, LAD1 was significantly upregulated, particularly in the cancer cell subgroup within tumors. Immunohistochemical results showed that LAD1 was highly expressed in LUAD, and knocking down LAD1 could inhibit LUAD cell migration and invasion. Pancancer analyses demonstrated LAD1 as an independent prognostic factor for overall survival in LUAD. Moreover, we developed a nomogram model incorporating LAD1 expression and clinical parameters, which demonstrated good predictive performance. The high expression of LAD1 in cancer cells, its associations with LUAD-related genes, and its links to biological processes and pathways suggest its potential biological relevance and that it merits further investigation. Overall, this study provides insights into LUAD and supports LAD1 as a gene worthy of further investigation.  \nKeywords Lung adenocarcinoma (LUAD), Single-cell RNA sequencing (scRNA-seq), LAD1, Migration, Invasion  \nLung cancer is a leading cause of morbidity and mortality worldwide1, with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) being the two main types. NSCLC, particularly lung adenocarcinoma (LUAD), accounts for the majority of lung cancer cases and poses a significant global health threat2. LUADis often diagnosed at advanced stages, resulting in poor prognosis3. Treatment options for LUAD include surgery, chemotherapy, radiotherapy, and immunotherapy, with targeted therapies showing promising results by inhibiting specific tyrosine kinase pathways such as EGFR, ALK, and ROS14. However, the genetic profiles of tumors can vary substantially between individuals, necessitating personalized therapeutic approaches based on gene expression patterns. Several genes have been identified as associated with LUAD tumorigenesis and prognosis, including those involved in signaling transduction, tumor microenvironment, and metabolism5–7. Nonetheless, the discovery of additional prognostic genes holds the potential to further enhance therapeutic outcomes in LUAD.  \n1Department of Pathology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China. 2Department of Ultrasound Medicine, Wuhu Hospital, East China Normal University (The Second People’s Hospital, Wu","cbCaitz5lC9ku0l3","https://ap.wps.com/l/cbCaitz5lC9ku0l3","pdf",10746315,17,"English","# Background\n## LUAD burden and biomarker need\n# Study Design and Analyses\n## Single-cell and bulk RNA-seq approach\n## Cell subgroups and LAD1 expression patterns\n## DEG, pathway, and process analyses\n# Experimental and Clinical Validation\n## Immunohistochemistry in LUAD tissues\n## siRNA knockdown in A549 cells\n## Migration and invasion assays\n# Prognostic Value and Modeling\n## Pancancer and survival analysis\n## Nomogram prediction model","[{\"question\":\"What data types and analysis strategies were used to study LAD1 in LUAD?\",\"answer\":\"The study uses single-cell RNA sequencing and bulk RNA sequencing for comprehensive analyses, including DEG, biological process, and signaling pathway investigations, along with clinical tissue correlation analyses.\"},{\"question\":\"Where is LAD1 expressed within LUAD tumors according to the single-cell results?\",\"answer\":\"LAD1 is specifically expressed in cancer cells within the LUAD tumor cell subgroup, rather than broadly across all examined cell types.\"},{\"question\":\"How does LAD1 knockdown affect LUAD cell behavior?\",\"answer\":\"siRNA-mediated LAD1 knockdown in A549 cells inhibits LUAD cell migration and invasion, supported by scratch healing and Transwell assays.\"}]","Exploring the expression and prognostic roles of LAD1 in lung adenocarcinoma | PDF",1790180189,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a5c876ed4573b56fffb1850ff7af982.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaadf61ddea7bad953449170bcd8301c.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/faea66b92be7616f93dbb982e5053945.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d478337e20563da7e8748a3b20a40478.webp",980,1287]